Jasper Therapeutics (JSPR) Short Interest Ratio & Short Volume → Elon’s New Device is About to Shock the World (From InvestorPlace) (Ad) Free JSPR Stock Alerts $21.33 -0.09 (-0.42%) (As of 05/10/2024 08:55 PM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Jasper Therapeutics Short Interest DataCurrent Short Volume614,400 sharesPrevious Short Volume492,400 sharesChange Vs. Previous Month+24.78%Dollar Volume Sold Short$14.67 millionShort Interest Ratio / Days to Cover5.4Last Record DateApril 30, 2024Outstanding Shares15,060,000 sharesFloat Size11,800,000 sharesShort Percent of Float5.21%Today's Trading Volume53,300 sharesAverage Trading Volume111,649 sharesToday's Volume Vs. Average48% Short Selling Jasper Therapeutics ? Sign up to receive the latest short interest report for Jasper Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatJSPR Short Interest Over TimeJSPR Days to Cover Over TimeJSPR Percentage of Float Shorted Over Time Ad Unstoppable ProsperityCharles Payne Demystifies OptionsWhen it comes to retirement, everyone fears one thing… Outliving their retirement savings. You'll discover conservative, beginner-friendly options strategies which could help to cash flow your stock portfolio. Click here to register for free. Jasper Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/2024614,400 shares $14.67 million +24.8%5.2%5.4 $23.87 4/15/2024492,400 shares $12.95 million +9.0%4.2%4.4 $26.30 3/31/2024451,900 shares $13.27 million +38.1%3.8%3.5 $29.36 3/15/2024327,300 shares $8.21 million +13.3%2.8%2.6 $25.08 2/29/2024288,900 shares $6.14 million +2.5%2.7%2.1 $21.25 2/15/2024282,000 shares $5.06 million +2.1%2.7%2.2 $17.95 Get the Latest News and Ratings for JSPR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Jasper Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 1/31/2024276,200 shares $3.25 million +43.5%3.4%2.5 $11.78 1/15/2024192,500 shares $1.62 million +4.5%2.4%2.2 $8.39 12/31/2023184,300 shares $1.45 million -90.4%2.3%3 $7.89 12/15/20231,910,000 shares $924,058.00 +0.5%2.4%3.1 $0.48 11/30/20231,900,000 shares $1.17 million +2.7%2.4%4.8 $0.61 11/15/20231,850,000 shares $1.06 million +1.1%2.3%5.3 $0.57 10/31/20231,830,000 shares $1.21 million -2.7%2.3%5.5 $0.66 10/15/20231,880,000 shares $1.64 million +6.8%2.4%5.7 $0.87 9/30/20231,760,000 shares $1.23 million +45.5%2.2%5.2 $0.70 9/15/20231,210,000 shares $992,200.00 +11.0%1.5%3.7 $0.82 8/31/20231,090,000 shares $1.34 million +9.0%1.4%4.1 $1.23 8/15/2023999,600 shares $1.44 million -1.0%1.3%3.6 $1.44 7/31/20231,010,000 shares $1.53 million +19.5%1.3%3.3 $1.51 7/15/2023845,500 shares $1.19 million +3.3%1.1%2.5 $1.41 6/30/2023818,600 shares $1.12 million +13.2%1.0%1.6 $1.37 6/15/2023723,100 shares $1.06 million -16.1%0.9%1.4 $1.47 5/31/2023861,500 shares $1.34 million -18.0%1.1%1.3 $1.55 5/15/20231,050,000 shares $1.64 million -16.7%1.3%1.2 $1.56 4/30/20231,260,000 shares $1.68 million -67.5%1.7%1.2 $1.33 4/15/20233,880,000 shares $5.63 million +5.7%4.8%2.9 $1.45 3/31/20233,670,000 shares $6.64 million +20.7%4.4%1.4 $1.81 3/15/20233,040,000 shares $5.78 million -12.1%3.6%0.8 $1.90 2/28/20233,460,000 shares $6.68 million +46.0%4.1%1 $1.93 2/15/20232,370,000 shares $4.14 million +76.9%2.8%0.7 $1.75 1/31/20231,340,000 shares $2.28 million +52.0%1.6%0.4 $1.70 1/15/2023881,800 shares $1.57 million +240.7%6.9%0.3 $1.78 12/30/2022258,800 shares $124,974.52 +21.6%2.0%0.1 $0.48 12/15/2022212,900 shares $137,022.44 +48.1%1.7%3.2 $0.64 11/30/2022143,800 shares $90,306.40 +30.6%1.2%2.2 $0.63 11/15/2022110,100 shares $71,565.00 +37.6%0.9%1.6 $0.65 10/31/202280,000 shares $58,400.00 +78.6%0.7%1.1 $0.73 10/15/202244,800 shares $32,475.52 -54.2%0.4%0.6 $0.72 9/30/202297,800 shares $77,173.98 +1,170.1%0.7%1.4 $0.79 9/15/20227,700 shares $10,010.00 -89.9%0.1%0.1 $1.30The Department of Defense Has a New Drone Contractor (Ad)The Department of Defense just granted a major advantage to a small UAV provider. Since 1998, this Nasdaq-listed company has been supplying drones for civilian, enterprise, and military purposes.Click here to see how to invest JSPR Short Interest - Frequently Asked Questions What is Jasper Therapeutics' current short interest? Short interest is the volume of Jasper Therapeutics shares that have been sold short but have not yet been closed out or covered. As of April 30th, traders have sold 614,400 shares of JSPR short. 5.21% of Jasper Therapeutics' shares are currently sold short. Learn More on Jasper Therapeutics' current short interest. What is a good short interest ratio for Jasper Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. JSPR shares currently have a short interest ratio of 5.0. Learn More on Jasper Therapeutics's short interest ratio. Which institutional investors are shorting Jasper Therapeutics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Jasper Therapeutics: Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Jasper Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 5.21% of Jasper Therapeutics' floating shares are currently sold short. Is Jasper Therapeutics' short interest increasing or decreasing? Jasper Therapeutics saw a increase in short interest in the month of April. As of April 30th, there was short interest totaling 614,400 shares, an increase of 24.8% from the previous total of 492,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Jasper Therapeutics' float size? Jasper Therapeutics currently has issued a total of 15,060,000 shares. Some of Jasper Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Jasper Therapeutics currently has a public float of 11,800,000 shares. How does Jasper Therapeutics' short interest compare to its competitors? 5.21% of Jasper Therapeutics' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Jasper Therapeutics: Tenaya Therapeutics, Inc. (5.80%), DocGo Inc. (10.25%), Black Diamond Therapeutics, Inc. (3.81%), Ocugen, Inc. (18.61%), Aura Biosciences, Inc. (6.95%), Solid Biosciences Inc. (3.01%), SOPHiA GENETICS SA (0.11%), Caribou Biosciences, Inc. (13.35%), MeiraGTx Holdings plc (1.76%), Replimune Group, Inc. (19.05%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Jasper Therapeutics stock? Short selling JSPR is an investing strategy that aims to generate trading profit from Jasper Therapeutics as its price is falling. JSPR shares are trading down $0.09 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Jasper Therapeutics? A short squeeze for Jasper Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of JSPR, which in turn drives the price of the stock up even further. How often is Jasper Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including JSPR, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: TNYA Short Interest Data DCGO Short Interest Data BDTX Short Interest Data OCGN Short Interest Data AURA Short Interest Data SLDB Short Interest Data SOPH Short Interest Data CRBU Short Interest Data MGTX Short Interest Data REPL Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:JSPR) was last updated on 5/13/2024 by MarketBeat.com Staff From Our PartnersThe Department of Defense Has a New Drone ContractorThe Tomorrow InvestorDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe Crypto 9-5 Escape PlanCrypto 101 MediaCharles Payne Demystifies OptionsUnstoppable ProsperityElon’s New Device is About to Shock the WorldInvestorPlaceThe A.I. story nobody is telling you (Read ASAP)TradeSmithElon to Transform U.S. Economy? Porter & CompanyBill Clinton Backing Biden Replacement???The Freeport Society